Mahen Gundecha
Chief Business Officer Exegenesis Bio
Seminars
2nd Presentation Session
Present your company’s slides by securing a 15-minute presentation slot in front of the attending audience.
What is this session?
To host as many innovative companies as possible on day one, this second session opens more presenting opportunities in front of the attending audience.
Presentation Sessions Remaining
3.15 – Tinostamustine, a Novel Approach for the Treatment of Central Nervous System Cancers Presentation by Imbrium Therapeutics
3.30 – Improved BBB Transport via Novel AAV Capsid Engineered to Bind to TfR1 Receptor Presentation by Exegenesis Bio
3.45 – The Opportunity for Neflamapimod in Age-Related Brain Disorders Presentation by CervoMed
4.00 – Reimagining Levodopa Therapy with Minitablets & the OraFID Device Presentation by Neurizon
4.15 – Risvodetinib as a Potential Disease Modifying Therapy for Neurodegenerative Disease Presentation by Navamedic
4.45 – Presentation by Agene Bio
5.00 – Presentation by Senovia Bioscience
5.15 – Why Short Lipidated Peptidomimetics (SLiPs) Could Change the World for Patients with Chronic Pain Presentation by Mimetic Medicines
